Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Brain Dev ; 36(6): 479-83, 2014 Jun.
Article in English | MEDLINE | ID: mdl-23969168

ABSTRACT

RATIONALE: Carnitine palmitoyltransferase (CPT) II is one of a pivotal enzyme in mitochondrial fatty acid oxidation, which is essential for energy production during simultaneous glucose sparing and a requirement for major energy supply, such as prolonged fasting or exercise. When infants require more energy than provided by the glycolytic system, they rely on the mitochondrial fatty acid oxidation pathway. Mutations of the CPT2 gene have been reported to cause sudden unexpected death in infancy (SUDI). A thermolabile phenotype of a CPT2 polymorphism (F352C) has been recently reported to reduce CPT II enzyme activity. The F352C variant results in energy crisis at high temperature and is suspected as a risk factor for acute encephalopathy. However, a relationship between CPT2 gene polymorphism and SUDI has not been described. METHODS: Single nucleotide polymorphisms of the CPT2 gene were investigated among 54 SUDI cases and 200 healthy volunteers. RESULTS: The frequency of the C allele was significantly higher in the SUDI group than in the control group [25.0% vs 16.0%, odds ratio (OR)=1.75, 95% confidence interval (CI)=1.05-2.92, p=0.030). The frequency of the F352C homozygote was significantly higher in the SUDI group than in control group (11.1% vs 3.5%, OR=3.45, 95% CI=1.11-10.73, p=0.036). CONCLUSION: The F352C CPT2 variant might be a genetic risk factor for SUDI.


Subject(s)
Carnitine O-Palmitoyltransferase/genetics , Genetic Predisposition to Disease , Polymorphism, Single Nucleotide , Sudden Infant Death/genetics , Female , Genotyping Techniques , Haplotypes , Humans , Infant , Infant, Newborn , Male , Odds Ratio , Retrospective Studies , Risk Factors
3.
J Obstet Gynaecol Res ; 39(1): 351-4, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22765161

ABSTRACT

A 31-year-old pregnant woman was transferred to the emergency room at 27 weeks of gestation. She had one-day history of fever and upper abdominal pain. Soon after admission, she underwent cardiopulmonary arrest. Autopsy was performed and multiple microthrombi were seen within the small-caliber vessels of many organs, but not in the lungs. Immunohistochemical staining revealed that the thrombi were rich in von Willebrand factor. We also obtained results which showed severely deficient plasma a disintegrin-like and metalloprotease with thrombospondin motifs (ADAMTS) 13 activity and positive ADAMTS13 inhibitor, confirming a diagnosis of thrombotic thrombocytopenic purpura. As far as we know, in Japan, this is the first autopsy report of sudden maternal death from thrombotic thrombocytopenic purpura. We expect that the routine laboratory application of ADAMTS13 assays for unknown thrombocytopenic patients during pregnancy may help in differential diagnosis at an earlier stage of the disease and facilitate tailor-made therapeutic intervention.


Subject(s)
Death, Sudden/pathology , Maternal Death , Purpura, Thrombotic Thrombocytopenic/pathology , Adult , Fatal Outcome , Female , Humans , Japan , Pregnancy
4.
Mol Genet Metab ; 106(4): 474-7, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22658691

ABSTRACT

Mitochondrial respiratory chain disorders are the most common disorders among inherited metabolic disorders. However, there are few published reports regarding the relationship between mitochondrial respiratory chain disorders and sudden unexpected death in infancy. In the present study, we performed metabolic autopsy in 13 Japanese cases of sudden unexpected death in infancy. We performed fat staining of liver and postmortem acylcarnitine analysis. In addition, we analyzed mitochondrial respiratory chain enzyme activity in frozen organs as well as in postmortem cultured fibroblasts. In heart, 11 cases of complex I activity met the major criteria and one case of complex I activity met the minor criteria. In liver, three cases of complex I activity met the major criteria and four cases of complex I activity met the minor criteria. However, these specimens are susceptible to postmortem changes and, therefore, correct enzyme analysis is hard to be performed. In cultured fibroblasts, only one case of complex I activity met the major criteria and one case of complex I activity met the minor criteria. Cultured fibroblasts are not affected by postmortem changes and, therefore, reflect premortem information more accurately. These cases might not have been identified without postmortem cultured fibroblasts. In conclusion, we detected one probable case and one possible case of mitochondrial respiratory chain disorders among 13 Japanese cases of sudden unexpected death in infancy. Mitochondrial respiratory chain disorders are one of the important inherited metabolic disorders causing sudden unexpected death in infancy. We advocate metabolic autopsy with postmortem cultured fibroblasts in sudden unexpected death in infancy cases.


Subject(s)
Fibroblasts/pathology , Mitochondrial Diseases/diagnosis , Postmortem Changes , Sudden Infant Death/diagnosis , Autopsy , Carnitine/analogs & derivatives , Carnitine/blood , Cells, Cultured , Electron Transport , Enzyme Assays , Female , Fibroblasts/enzymology , Humans , Infant , Infant, Newborn , Liver/enzymology , Liver/pathology , Male , Mitochondrial Diseases/blood , Mitochondrial Diseases/complications , Myocardium/enzymology , Myocardium/pathology , Sudden Infant Death/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...